Sangro B - Search Results

1

Tracing transgene expression in cancer gene therapy: a requirement for rational progress in the field.

Sangro B, Qian C, Ruiz J, Prieto J. Sangro B, et al. Mol Imaging Biol. 2002 Jan;4(1):27-33. doi: 10.1016/s1095-0397(01)00072-3. Mol Imaging Biol. 2002. PMID: 14538046

2

Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis.

Bilbao JI, Sangro B, Longo JM, Zozaya JM, Fernández-Virgós A, Aquerreta JD, Beloqui O, Prieto J. Bilbao JI, et al. Among authors: sangro b. Eur J Radiol. 1992 Oct;15(3):211-4. doi: 10.1016/0720-048x(92)90109-m. Eur J Radiol. 1992. PMID: 1337037

3

Hepatitis B and C viral infections in patients with hepatocellular carcinoma.

Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, Prieto J. Ruiz J, et al. Among authors: sangro b. Hepatology. 1992 Sep;16(3):637-41. doi: 10.1002/hep.1840160305. Hepatology. 1992. PMID: 1380480

4

Liver changes in patients with hyperthyroidism.

Sola J, Pardo-Mindán FJ, Zozaya J, Quiroga J, Sangro B, Prieto J. Sola J, et al. Among authors: sangro b. Liver. 1991 Aug;11(4):193-7. doi: 10.1111/j.1600-0676.1991.tb00516.x. Liver. 1991. PMID: 1943501

5

Ribavirin in desquamative interstitial pneumonia.

Prieto J, Sangro B, Beloqui O. Prieto J, et al. Among authors: sangro b. Chest. 1988 Feb;93(2):446-7. doi: 10.1378/chest.93.2.446b. Chest. 1988. PMID: 3338329 No abstract available.

6

Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion.

Fernández-Rodriguez CM, Prieto J, Quiroga J, Zozoya JM, Andrade A, Núñez M, Sangro B, Penas J. Fernández-Rodriguez CM, et al. Among authors: sangro b. Hepatology. 1995 Jan;21(1):35-40. doi: 10.1002/hep.1840210108. Hepatology. 1995. PMID: 7528711

7

Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.

Quiroga J, Sangro B, Núñez M, Bilbao I, Longo J, García-Villarreal L, Zozaya JM, Betés M, Herrero JI, Prieto J. Quiroga J, et al. Among authors: sangro b. Hepatology. 1995 Apr;21(4):986-94. Hepatology. 1995. PMID: 7705810

8

Partial splenic embolization for the treatment of hypersplenism in cirrhosis.

Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, Ruiz J, Zozaya JM, Quiroga J, Prieto J. Sangro B, et al. Hepatology. 1993 Aug;18(2):309-14. Hepatology. 1993. PMID: 8340060

9

Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome.

Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B, Sangro B. Prieto J, et al. Among authors: sangro b. Hepatology. 1996 Feb;23(2):199-204. doi: 10.1002/hep.510230201. Hepatology. 1996. PMID: 8591841

10

Partial splenic embolization in the treatment of thrombocytopenia after liver transplantation.

Herrero JI, Sangro B, Quiroga J, Bilbao JI, Yuste JR, Longo J, Pardo F, Hernández JL, Cienfuegos JA, Prieto J. Herrero JI, et al. Among authors: sangro b. Transplantation. 1997 Feb 15;63(3):482-4. doi: 10.1097/00007890-199702150-00029. Transplantation. 1997. PMID: 9039947 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters